An imbalance in reducing and oxidizing (redox) systems favoring a more oxidative environment is present in asthma and linked to the pathophysiology of the defining symptoms and signs including airflow limitation, hyper-reactivity, and airway remodeling. High levels of hydrogen peroxide, nitric oxide (•NO), and 15-F2t-isoprostane in exhaled breath, and excessive oxidative protein products in lung epithelial lining fluid, peripheral blood, and urine provide abundant evidence for pathologic oxidizing processes in asthma. Parallel studies document loss of reducing potential by nonenzymatic and enzymatic antioxidants. The essential first line antioxidant enzymes superoxide dismutases (SOD) and catalase are reduced in asthma as compared to healthy individuals, with lowest levels in those patients with the most severe asthma. Loss of SOD and catalase activity is related to oxidative modifications of the enzymes, while other antioxidant gene polymorphisms are linked to susceptibility to develop asthma. Monitoring of exhaled •NO has entered clinical practice because it is useful to optimize asthma care, and a wide array of other biochemical oxidative and nitrative biomarkers are currently being evaluated for asthma monitoring and phenotyping. Novel therapeutic strategies that target correction of redox abnormalities show promise for the treatment of asthma. Antioxid. Redox Signal. 12, 93–124.
Abu-SoudHM, HazenSL. Nitric oxide is a physiological substrate for mammalian peroxidases. J Biol Chem, 275:37524–37532. 2000.
2.
Abu-SoudHM, HazenSL. Nitric oxide modulates the catalytic activity of myeloperoxidase. J Biol Chem, 275:5425–5430. 2000.
3.
Abu-SoudHM, KhassawnehMY, SohnJT, MurrayP, HaxhiuMA, HazenSL. Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: Development of a model describing NO-peroxidase interactions. Biochemistry, 40:11866–11875. 2001.
4.
AdcockIM, BrownCR, KwonO, BarnesPJ. Oxidative stress induces NF kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun, 199:1518–1524. 1994.
5.
AganiFH, PichiuleP, ChavezJC, LaMannaJC. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem, 275:35863–35867. 2000.
6.
AlipourS, DeschampsF, LesageFX. Effects of environmental tobacco smoke on respiratory symptoms and pulmonary function. Inhal Toxicol, 18:569–573. 2006.
7.
AlvarezB, DemicheliV, DuranR, TrujilloM, CervenanskyC, FreemanBA, RadiR. Inactivation of human Cu, Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med, 37:813–822. 2004.
8.
AndreadisAA, HazenSL, ComhairSA, ErzurumSC. Oxidative and nitrosative events in asthma. Free Radic Biol Med, 35:213–225. 2003.
9.
AntczakA, MontuschiP, KharitonovS, GorskiP, BarnesPJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med, 166:301–306. 2002.
10.
ArcaroliJJ, HokansonJE, AbrahamE, GeraciM, MurphyJR, BowlerRP, DinarelloCA, SilveiraL, SankoffJ, HeylandD, WischmeyerP, CrapoJD. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Am J Resp Crit Care Med, 179:105–112. 2009.
11.
ChambellanA, LeahyR, XuW, CruickshankPJ, JanochaA, SzaboK, CannadySB, ComhairSA, ErzurumSC. Pivotal role of c-Fos in nitric oxide synthase 2 expression in airway epithelial cells. Nitric Oxide, 20:143–149. 2009.
12.
ArnerES, HolmgrenA. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 267:6102–6109. 2000.
13.
AulakKS, MiyagiM, YanL, WestKA, MassillonD, CrabbJW, StuehrDJ. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc Natl Acad Sci USA, 98:12056–12061. 2001.
14.
AvissarNE, ReedCK, CoxC, FramptonMW, FinkelsteinJN. Ozone, but not nitrogen dioxide, exposure decreases glutathione peroxidases in epithelial lining fluid of human lung. Am J Respir Crit Care Med, 162:1342–1347. 2000.
15.
BabiorBM. Oxygen-dependent microbial killing by phagocytes (first of two parts)N Engl J Med, 298:659–668. 1978.
16.
BabiorBM. Oxygen-dependent microbial killing by phagocytes (second of two parts)N Engl J Med, 298:721–725. 1978.
17.
BakerK, MarcusCB, HuffmanK, KrukH, MalfroyB, DoctrowSR. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: A key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther, 284:215–221. 1998.
BarnesPJ. Nitric oxide and asthma. Res Immunol, 146:698–702. 1995.
20.
BartoszG. Superoxide dismutase and catalase. Handbook Environment Chem, 2 part O:109–149. 2005.
21.
BastA, HaenenGR, DoelmanCJ. Oxidants and antioxidants: Sstate of the art. Am J Med, 91:2S–13S. 1991.
22.
Batinic-HaberleI. Manganese porphyrins and related compounds as mimics of superoxide dismutase. Methods Enzymol, 349:223–233. 2002.
23.
Batinic-HaberleI, BenovL, SpasojevicI, FridovichI. The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J Biol Chem, 273:24521–24528. 1998.
24.
BeckmanJS, IschiropoulosH, ZhuL, van der WoerdM, SmithC, ChenJ, HarrisonJ, MartinJC, TsaiM. Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys, 298:438–445. 1992.
25.
BelardinelliR, MucajA, LacalapriceF, SolenghiM, SeddaiuG, PrincipiF, TianoL, LittarruGP. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J, 27:2675–2681. 2006.
26.
BergtC, FuX, HuqNP, KaoJ, HeineckeJW. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem, 279:7856–7866. 2004.
27.
BiteauB, LabarreJ, ToledanoMB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature, 425:980–984. 2003.
28.
BolscherBG, PlatH, WeverR. Some properties of human eosinophil peroxidase, a comparison with other peroxidases. Biochim Biophys Acta, 784:177–186. 1984.
29.
BrennanML, WuW, FuX, ShenZ, SongW, FrostH, VadsethC, NarineL, LenkiewiczE, BorchersMT, LusisAJ, LeeJJ, LeeNA, Abu-SoudHM, IschiropoulosH, HazenSL. A tale of two controversies: Defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem, 277:17415–17427. 2002.
30.
BrigeliusR, MuckelC, AkerboomTP, SiesH. Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. Biochem Pharmacol, 32:2529–2534. 1983.
31.
BucchieriF, PuddicombeSM, LordanJL, RichterA, BuchananD, WilsonSJ, WardJ, ZummoG, HowarthPH, DjukanovicR, HolgateST, DaviesDE. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol, 27:179–185. 2002.
32.
Bucher TKM. Ege des Wasserstoffs in der Lebendigen Organisation. Angew Chem, 70:552–570. 1958.
33.
BuettnerGR. The pecking order of free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys, 300:535–543. 1993.
34.
BurnsJS, DockeryDW, NeasLM, SchwartzJ, CoullBA, RaizenneM, SpeizerFE. Low dietary nutrient intakes and respiratory health in adolescents. Chest, 132:238–245. 2007.
35.
BusseWW, ReedCE. MiddletonEJr, ReedCE, EllisEF, AdkinsonNFJr, YungingerJW, BusseWW. Asthma, Definition and Pathogenesis. Allergy, Principles and Practice, volume II. St Louis: Mosby-Year Book, 1992; 1173.
36.
BusseW, EliasJ, SheppardD, Banks-SchlegelS. Airway remodeling and repair. Am J Respir Crit Care Med, 160:1035–1042. 1999.
37.
CalhounWJ, ReedHE, MoestDR, StevensCA. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis, 145:317–325. 1992.
38.
CandeiasLP, PatelKB, StratfordMR, WardmanP. Free hydroxyl radicals are formed on reaction between the neutrophil-derived species superoxide anion and hypochlorous acid. FEBS Lett, 333:151–153. 1993.
39.
CantinAM, BeginR. Glutathione and inflammatory disorders of the lung. Lung, 169:123–138. 1991.
40.
CantinAM, HubbardRC, CrystalRG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis, 139:370–372. 1989.
41.
CantinAM, NorthSL, HubbardRC, CrystalRG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol, 63:152–157. 1987.
42.
CantinAM, Paquette. Oxidant and antioxidants in lung injury. Lam and other Diseases characterized by smooth muscle proliferation, 1999; 519–531.
43.
CantinA, CrystalRG. Oxidants, antioxidants and the pathogenesis of emphysema. Eur J Respir Dis, 139:7–17. 1985.
44.
CaoC, LengY, KufeD. Catalase activity is regulated by c-Abl and Arg in the oxidative stress response. J Biol Chem, 278:29667–29675. 2003.
45.
CarlsonMG, PetersonCG, VengeP. Human eosinophil peroxidase: Purification and characterization. J Immunol, 134:1875–1879. 1985.
46.
CarterEP, GaratC, ImamuraM. Continual emerging roles of HO-1: protection against airway inflammation. Am J Physiol Lung Cell Mol Physiol, 287:L24–25. 2004.
47.
CarvalhoH, EvelsonP, SigaudS, Gonzalez–FlechaB. Mitogen-activated protein kinases modulate H(2)O(2)-induced apoptosis in primary rat alveolar epithelial cells. J Cell Biochem, 92:502–513. 2004.
48.
CarverDJ, GastonB, DerondeK, PalmerLA. Akt-mediated activation of HIF-1 in pulmonary vascular endothelial cells by S-nitrosoglutathione. Am J Respir Cell Mol Biol, 37:255–263. 2007.
49.
ChaiYC, HoppeG, SearsJ. Reversal of protein S-glutathiolation by glutaredoxin in the retinal pigment epithelium. Exp Eye Res, 76:155–159. 2003.
50.
ChanceB. The properties of the enzyme-substrate compounds of horse-radish and lacto-peroxidase. Science, 109:204–208. 1949.
ChangLY, CrapoJD. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med, 33:379–386. 2002.
53.
ChangLY, KangBH, SlotJW, VincentR, CrapoJD. Immunocytochemical localization of the sites of superoxide dismutase induction by hyperoxia in rat lungs. Lab Invest, 73:29–39. 1995.
54.
CheesemanKH, SlaterTF. An introduction to free radical biochemistry. Br Med Bull, 49:481–493. 1993.
55.
ChoiAM, AlamJ. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol, 15:9–19. 1996.
56.
CiencewickiJ, TrivediS, KleebergerSR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol, 122:456–468. 2008quiz 469–470.
57.
ClydeBL, ChangLY, AutenRL, HoYS, CrapoJD. Distribution of manganese superoxide dismutase mRNA in normal and hyperoxic rat lung. Am J Respir Cell Mol Biol, 8:530–537. 1993.
58.
ComhairSA, BhathenaPR, DweikRA, KavuruM, ErzurumSC. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet, 355:624. 2000.
59.
ComhairSA, BhathenaPR, FarverC, ThunnissenFB, ErzurumSC. Extracellular glutathione peroxidase induction in asthmatic lungs: Evidence for redox regulation of expression in human airway epithelial cells. FASEB J, 15:70–78. 2001.
60.
ComhairSA, ErzurumSC. Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol, 283:L246–255. 2002.
61.
ComhairSA, ErzurumSC. The regulation and role of extracellular glutathione peroxidase. Antioxid Redox Signal, 7:72–79. 2005.
62.
ComhairSA, LewisMJ, BhathenaPR, HammelJP, ErzurumSC. Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med, 159:1824–1829. 1999.
63.
ComhairSA, RicciKS, ArroligaM, LaraAR, DweikRA, SongW, HazenSL, BleeckerER, BusseWW, ChungKF, GastonB, HastieA, HewM, JarjourN, MooreW, PetersS, TeagueWG, WenzelSE, ErzurumSC. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med, 172:306–313. 2005.
64.
ComhairSA, ThomassenMJ, ErzurumSC. Differential induction of extracellular glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 100% O(2) or cigarette smoke. Am J Respir Cell Mol Biol, 23:350–354. 2000.
65.
ComhairSA, XuW, GhoshS, ThunnissenFB, AlmasanA, CalhounWJ, JanochaAJ, ZhengL, HazenSL, ErzurumSC. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol, 166:663–674. 2005.
66.
ConnerEM, GrishamMB. Inflammation, free radicals, and antioxidants. Nutrition, 12:274–277. 1996.
67.
CookDG, StrachanDP. Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax, 54:357–366. 1999.
68.
CorradiM, FolesaniG, AndreoliR, ManiniP, BodiniA, PiacentiniG, CarraroS, ZanconatoS, BaraldiE. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Resp Crit Care Med, 167:395–399. 2003.
69.
CorradiM, MontuschiP, DonnellyLE, PesciA, KharitonovSA, BarnesPJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med, 163:854–858. 2001.
70.
CosioBG, MannB, ItoK, JazrawiE, BarnesPJ, ChungKF, AdcockIM. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med, 170:141–147. 2004.
71.
CramerR, SoranzoMR, PatriarcaP. Evidence that eosinophils catalyze the bromide-dependent decarboxylation of amino acids. Blood, 58:1112–1118. 1981.
72.
CrapoJD, OuryT, RabouilleC, SlotJW, ChangLY. Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA, 89:10405–10409. 1992.
73.
CrossCE, VasuVT, LimY, GohilK. Combating oxidative stress at respiratory tract biosurfaces: Challenges yet to be resolved, a commentary on “Vitamin supplementation does not protect against symptoms in ozone-responsive subjects”Free Radic Biol Med, 40:1693–1697. 2006.
74.
CrowJP, SampsonJB, ZhuangY, ThompsonJA, BeckmanJS. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J Neurochem, 69:1936–1944. 1997.
75.
CulpittSV, RogersDF, FenwickPS, ShahP, De MatosC, RussellRE, BarnesPJ, DonnellyLE. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax, 58:942–946. 2003.
76.
CuzzocreaS, RileyDP, CaputiAP, SalveminiD. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev, 53:135–159. 2001.
77.
DahlM, BowlerRP, JuulK, CrapoJD, LevyS, NordestgaardBG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med, 178:906–912. 2008.
78.
Dalle-DonneI, MilzaniA, GaglianoN, ColomboR, GiustariniD, RossiR. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal, 10:445–473. 2008.
79.
Dalle-DonneI, RossiR, GiustariniD, ColomboR, MilzaniA. S-glutathionylation in protein redox regulation. Free Radic Biol Med, 43:883–898. 2007.
80.
DasKC, Lewis-MolockY, WhiteCW. Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B. Mol Cell Biochem, 148:45–57. 1995.
81.
DaviesKJ. Oxidative stress: The paradox of aerobic life. Biochem Soc Symp, 61:1–31. 1995.
82.
De RaeveHR, ThunnissenFB, KanekoFT, GuoFH, LewisM, KavuruMS, SecicM, ThomassenMJ, ErzurumSC. Decreased Cu, Zn-SOD activity in asthmatic airway epithelium: Correction by inhaled corticosteroid in vivo. Am J Physiol, 272:L148–154. 1997.
83.
DeisserothA, DounceAL. Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role. Physiol Rev, 50:319–375. 1970.
84.
DenekeSM, FanburgBL. Regulation of cellular glutathione. Am J Physiol, 257:L163–173. 1989.
85.
DiazM, AchkorH, TitarenkoE, MartinezMC. The gene encoding glutathione-dependent formaldehyde dehydrogenase/GSNO reductase is responsive to wounding, jasmonic acid and salicylic acid. FEBS Lett, 543:136–139. 2003.
86.
DominiciS, ValentiniM, MaellaroE, Del BelloB, PaolicchiA, LorenziniE, TongianiR, ComportiM, PompellaA. Redox modulation of cell surface protein thiols in U937 lymphoma cells: The role of gamma-glutamyl transpeptidase-dependent H2O2 production and S-thiolation. Free Radic Biol Med, 27:623–635. 1999.
87.
DonzelliS, SwitzerCH, ThomasDD, RidnourLA, EspeyMG, IsenbergJS, TocchettiCG, KingSB, LazzarinoG, MirandaKM, RobertsDD, FeelischM, WinkDA. The activation of metabolites of nitric oxide synthase by metals is both redox and oxygen dependent: A new feature of nitrogen oxide signaling. Antioxid Redox Signal, 8:1363–1371. 2006.
88.
DowneyGP, FialkowL. FormanHF, CadenasE. Reactive oxygen intermediates as signaling molecules. Oxidative Stress and Signal Transduction, 1997; 415–441.
89.
DruilheA, WallaertB, TsicopoulosA, Lapa e SilvaJR, Tillie-LeblondI, TonnelAB, PretolaniM. Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol, 19:747–757. 1998.
90.
DuanYJ, KomuraS, Fiszer-SzafarzB, SzafarzD, YagiK. Purification and characterization of a novel monomeric glutathione peroxidase from rat liver. J Biol Chem, 263:19003–19008. 1988.
91.
DweikRA. The lung in the balance: Arginine, methylated arginines, and nitric oxide. Am J Physiol Lung Cell Mol Physiol, 292:L15–17. 2007.
92.
DweikRA, ComhairSA, GastonB, ThunnissenFB, FarverC, ThomassenMJ, KavuruM, HammelJ, Abu–SoudHM, ErzurumSC. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA, 98:2622–2627. 2001.
93.
DweikRA, LaskowskiD, Abu-SoudHM, KanekoF, HutteR, StuehrDJ, ErzurumSC. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest, 101:660–666. 1998.
94.
DworskiR, MurrayJJ, RobertsLJ2nd, OatesJA, MorrowJD, FisherL, ShellerJR. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med, 160:1947–1951. 1999.
95.
DworskiR, RobertsLJ2nd, MurrayJJ, MorrowJD, HartertTV, ShellerJR. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha)Clin Exp Allergy, 31:387–390. 2001.
96.
EatonP. Protein thiol oxidation in health and disease: Techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic Biol Med, 40:1889–1899. 2006.
97.
EisnerMD, KleinJ, HammondSK, KorenG, LactaoG, IribarrenC. Directly measured second hand smoke exposure and asthma health outcomes. Thorax, 60:814–821. 2005.
98.
ErzurumSC, DanelC, GillissenA, ChuCS, TrapnellBC, CrystalRG. In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2. J Appl Physiol, 75:1256–1262. 1993.
99.
EscribanoA, Garcia-GrandeA, MontanesP, MirallesL, GarciaA. Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: A feasibility study. Neoplasma, 49:201–208. 2002.
100.
FattmanCL, SchaeferLM, OuryTD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med, 35:236–256. 2003.
101.
FernandesAP, HolmgrenA. Glutaredoxins: Glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal, 6:63–74. 2004.
102.
FilomeniG, RotilioG, CirioloMR. Cell signalling and the glutathione redox system. Biochem Pharmacol, 64:1057–1064. 2002.
103.
FooteCS, GoyneTE, LehrerRI. Assessment of chlorination by human neutrophils. Nature, 301:715–716. 1983.
104.
ForesiA, BertorelliG, PesciA, ChettaA, OlivieriD. Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission. Chest, 98:528–535. 1990.
105.
FradetteC, YamaguchiN, Du SouichP. 5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide. Br J Pharmacol, 141:407–414. 2004.
106.
FreedmanJE, FreiB, WelchGN, LoscalzoJ. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest, 96:394–400. 1995.
107.
FridovichI. Superoxide dismutases. Annu Rev Biochem, 44:147–159. 1975.
108.
FridovichI. The biology of oxygen radicals. Science, 201:875–880. 1978.
109.
FridovichI, FreemanB. Antioxidant defenses in the lung. Annu Rev Physiol, 48:693–702. 1986.
GazdikF, GvozdjakovaA, NadvornikovaR, RepickaL, JahnovaE, KucharskaJ, PijakMR, GazdikovaK. Decreased levels of coenzyme Q(10) in patients with bronchial asthma. Allergy, 57:811–814. 2002.
117.
GhibelliL, CoppolaS, FanelliC, RotilioG, CivitarealeP, ScovassiAI, CirioloMR. Glutathione depletion causes cytochrome c release even in the absence of cell commitment to apoptosis. FASEB J, 13:2031–2036. 1999.
118.
GhibelliL, FanelliC, RotilioG, LafaviaE, CoppolaS, ColussiC, CivitarealeP, CirioloMR. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J, 12:479–486. 1998.
GhoshS, MasriF, ComhairS, AndreadisA, SwaidaniS, AronicaM, AulakK, ErzurumS. Nitration of proteins in murine model of asthma. Am J Respir Crit Care Med, 167:A889. 2003.
121.
GillilandFD, GaudermanWJ, VoraH, RappaportE, DubeauL. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med, 166:710–716. 2002.
122.
GiustariniD, Dalle-DonneI, LorenziniS, MilzaniA, RossiR. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J Gerontol, 61:1030–1038. 2006.
123.
GleichGJ, OttesenEA, LeifermanKM, AckermanSJ. Eosinophils and human disease. Int Arch Allergy Appl Immunol, 88:59–62. 1989.
124.
GoeptarAR, ScheerensH, VermeulenNP. Oxygen and xenobiotic reductase activities of cytochrome P450. Crit Rev Toxicol, 25:25–65. 1995.
125.
GossSP, SinghRJ, KalyanaramanB. Bicarbonate enhances the peroxidase activity of Cu,Zn-superoxide dismutase. Role of carbonate anion radical. J Biol Chem, 274:28233–28239. 1999.
126.
GuoFH, ComhairSA, ZhengS, DweikRA, EissaNT, ThomassenMJ, CalhounW, ErzurumSC. Molecular mechanisms of increased nitric oxide (NO) in asthma: Evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol, 164:5970–5980. 2000.
127.
GuoFH, De RaeveHR, RiceTW, StuehrDJ, ThunnissenFB, ErzurumSC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA, 92:7809–7813. 1995.
128.
GuoFH, ErzurumSC. Characterization of inducible nitric oxide synthase expression in human airway epithelium. Environ Health Perspect, 106,Suppl 5:1119–1124. 1998.
129.
GuoFH, UetaniK, HaqueSJ, WilliamsBR, DweikRA, ThunnissenFB, CalhounW, ErzurumSC. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest, 100:829–838. 1997.
HaahtelaT. Airway remodelling takes place in asthma—What are the clinical implications?Clin Exp Allergy, 27:351–353. 1997.
132.
HalliwellB. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence?Lancet, 344:721–724. 1994.
133.
HalliwellB, GutteridgeJM. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol, 186:1–85. 1990.
134.
HamannKJ, BarkerRL, TenRM, GleichGJ. The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol, 94:202–209. 1991.
135.
HarrisonDG, ChapmanMP, ChristyJP, MarcusML. Studies of functional site of origin of native coronary collaterals. Am J Physiol, 251:H1217–1224. 1986.
136.
HartLA, KrishnanVL, AdcockIM, BarnesPJ, ChungKF. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Resp Critical Care Med, 158:1585–1592. 1998.
137.
HazenSL, HsuFF, GautJP, CrowleyJR, HeineckeJW. Modification of proteins and lipids by myeloperoxidase. Methods Enzymol, 300:88–105. 1999.
138.
HazenSL, ZhangR, ShenZ, WuW, PodrezEA, MacPhersonJC, SchmittD, MitraSN, MukhopadhyayC, ChenY, CohenPA, HoffHF, Abu-SoudHM. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: Pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ Res, 85:950–958. 1999.
139.
HeffnerJE, RepineJE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis, 140:531–554. 1989.
140.
HendersonWRJr., ChiEY, TeoJL, NguyenC, KahnM. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol, 169:5294–5299. 2002.
141.
HigashiN, MitaH, TaniguchiM, TurikisawaN, HigashiA, OzawaY, TohmaS, ArimuraK, AkiyamaK. Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides. J Allergy Clin Immunol, 114:1353–1358. 2004.
142.
HolmgrenA. Thioredoxin and glutaredoxin systems. J Biol Chem, 264:13963–13966. 1989.
143.
HortonMA, LarsonKA, LeeJJ, LeeNA. Cloning of the murine eosinophil peroxidase gene (mEPO): Characterization of a conserved subgroup of mammalian hematopoietic peroxidases. J Leukoc Biol, 60:285–294. 1996.
144.
HorwitzRJ, BusseWW. Inflammation and asthma. Clin Chest Med, 16:583–602. 1995.
HouY, GuoZ, LiJ, WangPG. Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols. Biochem Biophys Res Commun, 228:88–93. 1996.
147.
HuFB, PerskyV, FlayBR, RichardsonJ. An epidemiological study of asthma prevalence and related factors among young adults. J Asthma, 34:67–76. 1997.
148.
HuX, XiaH, SrivastavaSK, HerzogC, AwasthiYC, JiX, ZimniakP, SinghSV. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun, 238:397–402. 1997.
149.
HuntJF, FangK, MalikR, SnyderA, MalhotraN, Platts–MillsTA, GastonB. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med, 161:694–699. 2000.
150.
HurdTR, FilipovskaA, CostaNJ, DahmCC, MurphyMP. Disulphide formation on mitochondrial protein thiols. Biochem Soc Trans, 33:1390–1393. 2005.
151.
IgnarroLJ, BugaGM, WeiLH, BauerPM, WuG, del SoldatoP. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA, 98:4202–4208. 2001.
152.
IijimaH, DuguetA, EumSY, HamidQ, EidelmanDH. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med, 163:1233–1240. 2001.
Institute NNhlab. National asthma eduction and prevention program. Expert panel report 2:Guidelines for the diagnosis and management of asthma. 1997; 4051p. Publication no. 97.
155.
IslamT, BerhaneK, McConnellR, GaudermanWJ, AvolE, PetersJM, GillilandFD. Glutathione-S-transferase (GST) P1, GSTM1, exercise, ozone and asthma incidence in school children. Thorax, 64:197–202. 2009.
156.
JaakkolaMS, JaakkolaJJ. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health, 28,Suppl 2:52–70. 2002.
157.
JaakkolaMS, JaakkolaJJ. Impact of smoke-free workplace legislation on exposures and health: Possibilities for prevention. Eur Respir J, 28:397–408. 2006.
158.
JansonC, ChinnS, JarvisD, ZockJP, TorenK, BurneyP. Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: A cross-sectional study. Lancet, 358:2103–2109. 2001.
159.
JarjourNN, BusseWW, CalhounWJ. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis, 146:905–911. 1992.
160.
JarjourNN, CalhounWJ. Enhanced production of oxygen radicals in asthma. J Lab Clin Med, 123:131–136. 1994.
161.
JatakanonA, UasufC, MaziakW, LimS, ChungKF, BarnesPJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med, 160:1532–1539. 1999.
162.
JiangQ, ChristenS, ShigenagaMK, AmesBN. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr, 74:714–722. 2001.
163.
JindalSK, GuptaD, SinghA. Indices of morbidity and control of asthma in adult patients exposed to environmental tobacco smoke. Chest, 106:746–749. 1994.
164.
JindalSK, JhaLK, GuptaD. Bronchial hyper-responsiveness of women with asthma exposed to environmental tobacco smoke. Indian J Chest Dis Allied Sci, 41:75–82. 1999.
165.
JorresR, NowakD, MagnussenH. The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis. Am J Respir Crit Care Med, 153:56–64. 1996.
166.
Jourd'heuilD, LarouxFS, MilesAM, WinkDA, GrishamMB. Effect of superoxide dismutase on the stability of S-nitrosothiols. Arch Biochem Biophys, 361:323–330. 1999.
167.
JungasT, MottaI, DuffieuxF, FanenP, StovenV, OjciusDM. Glutathione levels and BAX activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator. J Biol Chem, 277:27912–27918. 2002.
168.
JuulK, Tybjaerg-HansenA, MarklundS, LangeP, NordestgaardBG. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 173:858–864. 2006.
169.
KafouryRM, PryorWA, SquadritoGL, SalgoMG, ZouX, FriedmanM. Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. Am J Respir Crit Care Med, 160:1934–1942. 1999.
170.
KafouryRM, PryorWA, SquadritoGL, SalgoMG, ZouX, FriedmanM. Lipid ozonation products activate phospholipases A2, C, and D. Toxicol App Pharmacol, 150:338–349. 1998.
171.
KarlssonK, MarklundSL. Heparin-, dextran sulfate- and protamine-induced release of extracellular-superoxide dismutase to plasma in pigs. Biochim Biophys Acta, 967:110–114. 1988.
172.
KharitonovSA, YatesD, RobbinsRA, Logan–SinclairR, ShinebourneEA, BarnesPJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet, 343:133–135. 1994.
173.
KhatriSB, HammelJ, KavuruMS, ErzurumSC, DweikRA. Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge. J Appl Physiol, 95:436–440. 2003discussion 435.
174.
KhatriSB, OzkanM, McCarthyK, LaskowskiD, HammelJ, DweikRA, ErzurumSC. Alterations in exhaled gas profile during allergen-induced asthmatic response. Am J Respir Crit Care Med, 164:1844–1848. 2001.
175.
KiersteinS, KrytskaK, SharmaS, AmraniY, SalmonM, PanettieriRAJr., ZangrilliJ, HaczkuA. Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen-sensitized mice. Allergy, 63:438–446. 2008.
176.
KinnulaVL. Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax, 60:693–700. 2005.
177.
KinnulaVL, CrapoJD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med, 167:1600–1619. 2003.
178.
KinnulaVL, EverittJI, WhortonAR, CrapoJD. Hydrogen peroxide production by alveolar type II cells, alveolar macrophages, and endothelial cells. Am J Physiol, 261:L84–91. 1991.
179.
KinnulaVL, LehtonenS, Kaarteenaho-WiikR, LakariE, PaakkoP, KangSW, RheeSG, SoiniY. Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax, 57:157–164. 2002.
180.
KinnulaVL, LehtonenS, KoistinenP, KakkoS, SavolainenM, KereJ, OllikainenV, LaitinenT. Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax, 59:116–119. 2004.
181.
KirkmanHN, RolfoM, FerrarisAM, GaetaniGF. Mechanisms of protection of catalase by NADPH. Kinetics and stoichiometry. J Biol Chem, 274:13908–13914. 1999.
182.
KlattP, MolinaEP, De LacobaMG, PadillaCA, Martinez–GalesteoE, BarcenaJA, LamasS. Redox regulation of c-Jun DNA binding by reversible S-glutathiolation. FASEB J, 13:1481–1490. 1999.
183.
KlebanoffSJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med, 93:480–489. 1980.
184.
KlebanoffSJ, HamonCB. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc, 12:170–196. 1972.
185.
KlebanoffSJCRA. The Neutrophil: Function and Clinical Disorders. Amsterdam: Elsevier/North Holland Biomedical Press, 1978.
186.
KlimentCR, EnglertJM, GochuicoBR, YuG, KaminskiN, RosasI, OuryTD. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem, 284:3537–3545. 2009.
187.
KobzikL, BredtDS, LowensteinCJ, DrazenJ, GastonB, SugarbakerD, StamlerJS. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol, 9:371–377. 1993.
188.
KodeA, RajendrasozhanS, CaitoS, YangSR, MegsonIL, RahmanI. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol, 294:L478–488. 2008.
189.
KohYY, DupuisR, PolliceM, AlbertineKH, FishJE, PetersSP. Neutrophils recruited to the lungs of humans by segmental antigen challenge display a reduced chemotactic response to leukotriene B4. Am J Respir Cell Mol Biol, 8:493–499. 1993.
190.
KorenHS, BrombergPA. Respiratory responses of asthmatics to ozone. Intl Arch Allergy Immunol, 107:236–238. 1995.
191.
KunzliN, SchwartzJ, StutzEZ, Ackermann-LiebrichU, LeuenbergerP. Association of environmental tobacco smoke at work and forced expiratory lung function among never smoking asthmatics and non-asthmatics. The SAPALDIA-Team. Swiss Study on Air Pollution and Lung Disease in Adults. Soz Praventivmed, 45:208–217. 2000.
192.
KurokiM, VoestEE, AmanoS, BeerepootLV, TakashimaS, TolentinoM, KimRY, RohanRM, ColbyKA, YeoKT, AdamisAP. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest, 98:1667–1675. 1996.
193.
LakariE, PaakkoP, KinnulaVL. Manganese superoxide dismutase, but not CuZn superoxide dismutase, is highly expressed in the granulomas of pulmonary sarcoidosis and extrinsic allergic alveolitis. Am J Respir Crit Care Med, 158:589–596. 1998.
194.
LakariE, PaakkoP, Pietarinen-RunttiP, KinnulaVL. Manganese superoxide dismutase and catalase are coordinately expressed in the alveolar region in chronic interstitial pneumonias and granulomatous diseases of the lung. Am J Resp Crit Care Med, 161:615–621. 2000.
195.
LancasterJRJr., GastonB. NO and nitrosothiols: Spatial confinement and free diffusion. Am J Physiol Lung Cell Mol Physiol, 287:L465–466. 2004.
196.
LaneC, KnightD, BurgessS, FranklinP, HorakF, LeggJ, MoellerA, StickS. Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath. Thorax, 59:757–760. 2004.
197.
LarsenGL, WhiteCW, TakedaK, LoaderJE, NguyenDD, JoethamA, GronerY, GelfandEW. Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am J Physiol Lung Cell Mol Physiol, 279:L350–359. 2000.
198.
LarssonML, LoitHM, MerenM, PollusteJ, MagnussonA, LarssonK, LundbackB. Passive smoking and respiratory symptoms in the FinEsS Study. Eur Respir J, 21:672–676. 2003.
199.
LeeCG, LinkH, BalukP, HomerRJ, ChapovalS, BhandariV, KangMJ, CohnL, KimYK, McDonaldDM, EliasJA. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med, 10:1095–1103. 2004.
200.
LeeYL, HsiueTR, LeeYC, LinYC, GuoYL. The association between glutathione S-transferase P1, M1 polymorphisms and asthma in Taiwanese schoolchildren. Chest, 128:1156–1162. 2005.
201.
LehtonenST, OhlmeierS, Kaarteenaho-WiikR, HarjuT, PaakkoP, SoiniY, KinnulaVL. Does the oxidative stress in chronic obstructive pulmonary disease cause thioredoxin/peroxiredoxin oxidation?Antioxid Redox Signal, 10:813–819. 2008.
202.
LeikaufGD, ZhaoQ, ZhouS, SantrockJ. Ozonolysis products of membrane fatty acids activate eicosanoid metabolism in human airway epithelial cells. Am J Respir Cell Mol Biol, 9:594–602. 1993.
203.
LeonardSS, XiaC, JiangBH, StinefeltB, KlandorfH, HarrisGK, ShiX. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun, 309:1017–1026. 2003.
204.
LeuenbergerP, SchwartzJ, Ackermann-LiebrichU, BlaserK, BologniniG, BongardJP, BrandliO, BraunP, BronC, BrutscheMet al.Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med, 150:1222–1228. 1994.
205.
LiX, WilsonJW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med, 156:229–233. 1997.
LindC, GerdesR, HamnellY, Schuppe-KoistinenI, von LowenhielmHB, HolmgrenA, CotgreaveIA. Identification of S-glutathionylated cellular proteins during oxidative stress and constitutive metabolism by affinity purification and proteomic analysis. Arch Biochem Biophys, 406:229–240. 2002.
LondonSJ. Gene-air pollution interactions in asthma. Proc Am Thor Soc, 4:217–220. 2007.
211.
LundbergJO, Farkas-SzallasiT, WeitzbergE, RinderJ, LidholmJ, AnggaardA, HokfeltT, LundbergJM, AlvingK. High nitric oxide production in human paranasal sinuses. Nat Med, 1:370–373. 1995.
212.
LundstromJ, HolmgrenA. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem, 265:9114–9120. 1990.
213.
MacMillan-CrowLA, CrowJP, KerbyJD, BeckmanJS, ThompsonJA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA, 93:11853–11858. 1996.
214.
MacMillan-CrowLA, CrowJP, ThompsonJA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry, 37:1613–1622. 1998.
MacMillan-CrowLA, ThompsonJA. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys, 366:82–88. 1999.
217.
MacPhersonJC, ComhairSA, ErzurumSC, KleinDF, LipscombMF, KavuruMS, SamoszukMK, HazenSL. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: Characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol, 166:5763–5772. 2001.
218.
MaehlyAC, ChanceB. The assay of catalases and peroxidases. Meth Biochem Anal, 1:357–424. 1954.
MarklundSL, KarlssonKedited by al. ELeExtracellular-superoxide dismutase, distribution in the body and therapeutic applications. Therapy and Preventive Medicine. New York: Plenum Press, 1990; 1–4.
221.
Marks–KonczalikJ, ChuSC, MossJ. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem, 273:22201–22208. 1998.
222.
MartinRJ, CicuttoLC, SmithHR, BallardRD, SzeflerSJ. Airways inflammation in nocturnal asthma. Am Rev Respir Dis, 143:351–357. 1991.
223.
MasiniE, BaniD, VannacciA, PierpaoliS, MannaioniPF, ComhairSA, XuW, MuscoliC, ErzurumSC, SalveminiD. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic Biol Med, 39:520–531. 2005.
224.
MasriFA, ComhairSA, KoeckT, XuW, JanochaA, GhoshS, DweikRA, GolishJ, KinterM, StuehrDJ, ErzurumSC, AulakKS. Abnormalities in nitric oxide and its derivatives in lung cancer. Am J Respir Crit Care Med, 172:597–605. 2005.
225.
MatsueH, EdelbaumD, ShalhevetD, MizumotoN, YangC, MummertME, OedaJ, MasayasuH, TakashimaA. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol, 171:3010–3018. 2003.
226.
MayenoAN, CurranAJ, RobertsRL, FooteCS. Eosinophils preferentially use bromide to generate halogenating agents. J Biol Chem, 264:5660–5668. 1989.
227.
McCayPB. Vitamin E: interactions with free radicals and ascorbate. Annu Rev Nutr, 5:323–340. 1985.
228.
McCordJM, FridovichI. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)J Biol Chem, 244:6049–6055. 1969.
229.
McCreanorJ, CullinanP, NieuwenhuijsenMJ, Stewart–EvansJ, MalliarouE, JarupL, HarringtonR, SvartengrenM, HanIK, Ohman-StricklandP, ChungKF, ZhangJ. Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med, 357:2348–2358. 2007.
230.
MeisterA, AndersonME. Glutathione. Annu Rev Biochem, 52:711–760. 1983.
231.
MelovS, RavenscroftJ, MalikS, GillMS, WalkerDW, ClaytonPE, WallaceDC, MalfroyB, DoctrowSR, LithgowGJ. Extension of life-span with superoxide dismutase/catalase mimetics. Science, 289:1567–1569. 2000.
232.
MenziesD, NairA, WilliamsonPA, SchembriS, Al-KhairallaMZ, BarnesM, FardonTC, McFarlaneL, MageeGJ, LipworthBJ. Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places. JAMA, 296:1742–1748. 2006.
233.
MezzettiA, LapennaD, PierdomenicoSD, CalafioreAM, CostantiniF, Riario-SforzaG, ImbastaroT, NeriM, CuccurulloF. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis, 112:91–99. 1995.
MikerovAN, UmsteadTM, GanX, HuangW, GuoX, WangG, PhelpsDS, FlorosJ. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol, 294:L121–130. 2008.
236.
MitaH, HigashiN, TaniguchiM, HigashiA, AkiyamaK. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge. Clin Exp Allergy, 34:1262–1269. 2004.
237.
MondinoC, CiabattoniG, KochP, PistelliR, TroveA, BarnesPJ, MontuschiP. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol, 114:761–767. 2004.
238.
MontefortS, GratziouC, GouldingD, PolosaR, HaskardDO, HowarthPH, HolgateST, CarrollMP. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest, 93:1411–1421. 1994.
239.
MontuschiP, BarnesPJ. Isoprostanes and asthma. Drug Discov Today: Therap Strat, 3:287–292. 2006.
240.
MontuschiP, CorradiM, CiabattoniG, NightingaleJ, KharitonovSA, BarnesPJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med, 160:216–220. 1999.
241.
MontuschiP, MondinoC, KochP, BarnesPJ, CiabattoniG. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol, 118:347–353. 2006.
242.
MontuschiP, NightingaleJA, KharitonovSA, BarnesPJ. Ozone-induced increase in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Free Radic Biol Med, 33:1403–1408. 2002.
243.
MooreWC, BleeckerER, Curran-EverettD, ErzurumSC, AmeredesBT, BacharierL, CalhounWJ, CastroM, ChungKF, ClarkMP, DweikRA, FitzpatrickAM, GastonB, HewM, HussainI, JarjourNN, IsraelE, LevyBD, MurphyJR, PetersSP, TeagueWG, MeyersDA, BusseWW, WenzelSE. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol, 119:405–413. 2007.
244.
MudwayIS, KellyFJ. Ozone and the lung: A sensitive issue. Mol Aspects Med, 21:1–48. 2000.
245.
NakamuraH, De RosaSC, YodoiJ, HolmgrenA, GhezziP, HerzenbergLA, HerzenbergLA. Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci USA, 98:2688–2693. 2001.
246.
NakamuraH, NakamuraK, YodoiJ. Redox regulation of cellular activation. Ann Rev Immunol, 15:351–369. 1997.
247.
NakamuraT, NakamuraH, HoshinoT, UedaS, WadaH, YodoiJ. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal, 7:60–71. 2005.
248.
NguyenC, TeoJL, MatsudaA, EguchiM, ChiEY, HendersonWRJr., KahnM. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci USA, 100:1169–1173. 2003.
249.
NickelR, HaiderA, SenglerC, LauS, NiggemannB, DeichmannKA, WahnU, HeinzmannA. Association study of glutathione S-transferase P1 (GSTP1) with asthma and bronchial hyper-responsiveness in two German pediatric populations. Pediatr Allergy Immunol, 16:539–541. 2005.
250.
NordbergJ, ArnerES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med, 31:1287–1312. 2001.
251.
NovakZ, NemethI, GyurkovitsK, VargaSI, MatkovicsB. Examination of the role of oxygen free radicals in bronchial asthma in childhood. Clin Chim Acta, 201:247–251. 1991.
252.
O'ConnorGT, WeissST, TagerIB, SpeizerFE. The effect of passive smoking on pulmonary function and nonspecific bronchial responsiveness in a population-based sample of children and young adults. Am Rev Respir Dis, 135:800–804. 1987.
253.
O'SullivanMP, TynerJW, HoltzmanMJ. Apoptosis in the airways: Another balancing act in the epithelial program. Am J Respir Cell Mol Biol, 29:3–7. 2003.
254.
OlsenRL, LittleC. Purification and some properties of myeloperoxidase and eosinophil peroxidase from human blood. Biochem J, 209:781–787. 1983.
255.
OlssonI, PerssonAM, StrombergK, WinqvistI, TaiPC, SpryCJ. Purification of eosinophil peroxidase and studies of biosynthesis and processing in human marrow cells. Blood, 66:1143–1148. 1985.
256.
OuryTD, ChangLY, MarklundSL, DayBJ, CrapoJD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest, 70:889–898. 1994.
257.
OuryTD, DayBJ, CrapoJD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Rad Biol Med, 20:957–965. 1996.
258.
OuryTD, SchaeferLM, FattmanCL, ChoiA, WeckKE, WatkinsSC. Depletion of pulmonary EC-SOD after exposure to hyperoxia. Am J Physiol Lung Cell Mol Physiol, 283:L777–784. 2002.
259.
ParediP, KharitonovSA, BarnesPJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med, 166:S31–37. 2002.
260.
PascualRM, PetersSP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol, 116:477–486. 2005quiz 487.
261.
PedenDB, BoehleckeB, HorstmanD, DevlinR. Prolonged acute exposure to 0.16 ppm ozone induces eosinophilic airway inflammation in asthmatic subjects with allergies. J Allergy Clin Immunol, 100:802–808. 1997.
262.
PeltoniemiM, Kaarteenaho-WiikR, SailyM, SormunenR, PaakkoP, HolmgrenA, SoiniY, KinnulaVL. Expression of glutaredoxin is highly cell specific in human lung and is decreased by transforming growth factor-beta in vitro and in interstitial lung diseases in vivo. Human Pathol, 35:1000–1007. 2004.
263.
Perrin-NadifR, AuburtinG, DuschM, PorcherJM, MurJM. Blood antioxidant enzymes as markers of exposure or effect in coal miners. Occup Environ Med, 53:41–45. 1996.
264.
PerssonMG, ZetterstromO, AgreniusV, IhreE, GustafssonLE. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet, 343:146–147. 1994.
265.
PetersonJD, HerzenbergLA, VasquezK, WaltenbaughC. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA, 95:3071–3076. 1998.
266.
Pietarinen-RunttiP, RaivioKO, SakselaM, AsikainenTM, KinnulaVL. Antioxidant enzyme regulation and resistance to oxidants of human bronchial epithelial cells cultured under hyperoxic conditions. Am J Respir Cell Mol Biol, 19:286–292. 1998.
267.
PodrezEA, SchmittD, HoffHF, HazenSL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest, 103:1547–1560. 1999.
268.
PossKD, TonegawaS. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA, 94:10925–10930. 1997.
269.
PostmaDS, RenkemaTE, NoordhoekJA, FaberH, SluiterHJ, KauffmanH. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction. Am Rev Respir Dis, 137:57–61. 1988.
270.
PouS, KeatonL, SurichamornW, RosenGM. Mechanism of superoxide generation by neuronal nitric-oxide synthase. J Biol Chem, 274:9573–9580. 1999.
271.
PouS, PouWS, BredtDS, SnyderSH, RosenGM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem, 267:24173–24176. 1992.
272.
PowisG. Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther, 35:57–162. 1987.
273.
QueLG, LiuL, YanY, WhiteheadGS, GavettSH, SchwartzDA, StamlerJS. Protection from experimental asthma by an endogenous bronchodilator. Science, 308:1618–1621. 2005.
274.
RahmanI. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: Antioxidant therapeutic targets. Current Drug Targets, 1:291–315. 2002.
275.
RahmanI. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol, 36:95–109. 2003.
276.
RahmanI, AdcockIM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J, 28:219–242. 2006.
277.
RahmanI, AntonicelliF, MacNeeW. Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem, 274:5088–5096. 1999.
278.
RahmanI, BelA, MulierB, DonaldsonK, MacNeeW. Differential regulation of glutathione by oxidants and dexamethasone in alveolar epithelial cells. Am J Physiol, 275:L80–86. 1998.
279.
RahmanI, BiswasSK, KodeA. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol, 533:222–239. 2006.
280.
RahmanI, MacNeeW. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J, 16:534–554. 2000.
281.
RahmanI, SmithCA, LawsonMF, HarrisonDJ, MacNeeW. Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett, 396:21–25. 1996.
282.
RahmanI, SwarskaE, HenryM, StolkJ, MacNeeW. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?Thorax, 55:189–193. 2000.
283.
ReaumeAG, ElliottJL, HoffmanEK, KowallNW, FerranteRJ, SiwekDF, WilcoxHM, FloodDG, BealMF, BrownRHJr., ScottRW, SniderWD. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet, 13:43–47. 1996.
284.
ReichardP. From RNA to DNA, why so many ribonucleotide reductases?Science, 260:1773–1777. 1993.
285.
ReidTJ3rd, MurthyMR, SicignanoA, TanakaN, MusickWD, RossmannMG. Structure and heme environment of beef liver catalase at 2.5 A resolution. Proc Natl Acad Sci USA, 78:4767–4771. 1981.
286.
ReynaertNL, CklessK, GualaAS, WoutersEF, van der VlietA, Janssen-HeiningerYM. In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta, 1760:380–387. 2006.
287.
ReynaertNL, WoutersEF, Janssen-HeiningerYM. Modulation of glutaredoxin-1 expression in a mouse model of allergic airway disease. Am J Respir Cell Mol Biol, 36:147–151. 2007.
288.
RheeSG, KimKH, ChaeHZ, YimMB, UchidaK, NettoLE, StadtmanER. Antioxidant defense mechanisms: A new thiol-specific antioxidant enzyme. Ann NY Acad Sci, 738:86–92. 1994.
289.
RobertsMC, PangY, RileyDE, HillierSL, BergerRC, KriegerJN. Detection of Tet M and Tet O tetracycline resistance genes by polymerase chain reaction. Mol Cell Probes, 7:387–393. 1993.
290.
RoumJH, BuhlR, McElvaneyNG, BorokZ, CrystalRG. Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol, 75:2419–2424. 1993.
291.
RowleyDA, HalliwellB. Formation of hydroxyl radicals from hydrogen peroxide and iron salts by superoxide- and ascorbate-dependent mechanisms: relevance to the pathology of rheumatoid disease. Clin Sci, 64:649–653. 1983.
292.
RubinRN, NavonL, CassanoPA. Relationship of serum antioxidants to asthma prevalence in youth. Am J Respir Crit Care Med, 169:393–398. 2004.
293.
SakamakiK, TomonagaM, TsukuiK, NagataS. Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. J Biol Chem, 264:16828–16836. 1989.
294.
SalehD, ErnstP, LimS, BarnesPJ, GiaidA. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid. Faseb J, 12:929–937. 1998.
295.
SalvatoG. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax, 56:902–906. 2001.
296.
SalveminiD, MazzonE, DugoL, RileyDP, SerrainoI, CaputiAP, CuzzocreaS. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br J Pharmacol, 132:815–827. 2001.
297.
SalveminiD, MazzonE, DugoL, SerrainoI, De SarroA, CaputiAP, CuzzocreaS. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum, 44:2909–2921. 2001.
298.
SalveminiD, WangZQ, ZweierJL, SamouilovA, MacarthurH, MiskoTP, CurrieMG, CuzzocreaS, SikorskiJA, RileyDP. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science, 286:304–306. 1999.
299.
SandersSP. Nitric oxide in asthma. Pathogenic, therapeutic, or diagnostic?Am J Respir Cell Mol Biol, 21:147–149. 1999.
300.
SandersSP, ZweierJL, HarrisonSJ, TrushMA, RembishSJ, LiuMC. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am J Respir Crit Care Med, 151:1725–1733. 1995.
301.
SandstromJ, NilssonP, KarlssonK, MarklundSL. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem, 269:19163–19166. 1994.
302.
SchaferFQ, BuettnerGR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med, 30:1191–1212. 2001.
303.
ScheweT. Molecular actions of ebselen—An antiinflammatory antioxidant. Gen Pharmacol, 26:1153–1169. 1995.
304.
Schulze-OsthoffK, LosM, BaeuerlePA. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol, 50:735–741. 1995.
305.
SedgwickJB, CalhounWJ, VrtisRF, BatesME, McAllisterPK, BusseWW. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol, 149:3710–3718. 1992.
306.
SenCK, PackerL. Antioxidant and redox regulation of gene transcription. FASEB J, 10:709–720. 1996.
SilkoffPE, CaramoriM, TremblayL, McCleanP, ChaparroC, KestenS, HutcheonM, SlutskyAS, ZamelN, KeshavjeeS. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med, 157:1822–1828. 1998.
309.
SimonAR, RaiU, FanburgBL, CochranBH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol, 275:C1640–1652. 1998.
310.
SinghRJ, GossSP, JosephJ, KalyanaramanB. Nitration of gamma-tocopherol and oxidation of alpha-tocopherol by copper-zinc superoxide dismutase/H2O2/NO2-: Role of nitrogen dioxide free radical. Proc Natl Acad Sci USA, 95:12912–12917. 1998.
311.
SinghS, EvansTW. Nitric oxide, the biological mediator of the decade: Fact or fiction?Eur Respir J, 10:699–707. 1997.
312.
SmithLJ, HoustonM, AndersonJ. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis, 147:1461–1464. 1993.
313.
SmithLJ, ShamsuddinM, SpornPH, DenenbergM, AndersonJ. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med, 22:1301–1307. 1997.
314.
SoiniY, KahlosK, NapankangasU, Kaarteenaho-WiikR, SailyM, KoistinenP, PaaakkoP, HolmgrenA, KinnulaVL. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res, 7:1750–1757. 2001.
315.
SpasojevicI, Batinic–HaberleI, StevensRD, HambrightP, ThorpeAN, GrodkowskiJ, NetaP, FridovichI. Manganese(III) biliverdin IX dimethyl ester: a powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple. Inorg Chem, 40:726–739. 2001.
316.
StarkeDW, ChockPB, MieyalJJ. Glutathione-thiyl radical scavenging and transferase properties of human glutaredoxin (thioltransferase). Potential role in redox signal transduction. J Biol Chem, 278:14607–14613. 2003.
317.
StrangeRC, SpiteriMA, RamachandranS, FryerAA. Glutathione-S-transferase family of enzymes. Mutation Res, 482:21–26. 2001.
SundbergK, JohanssonAS, StenbergG, WiderstenM, SeidelA, MannervikB, JernstromB. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis, 19:433–436. 1998.
324.
SuttonA, KhouryH, Prip-BuusC, CepanecC, PessayreD, DegoulF. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics, 13:145–157. 2003.
TanizakiY, KitaniH, MifuneT, MitsunobuF, KajimotoK, SugimotoK. Effects of glucocorticoids on humoral and cellular immunity and on airway inflammation in patients with steroid-dependent intractable asthma. J Asthma, 30:485–492. 1993.
327.
TenRM, PeaseLR, McKeanDJ, BellMP, GleichGJ. Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med, 169:1757–1769. 1989.
328.
ThomasJA, PolandB, HonzatkoR. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys, 319:1–9. 1995.
329.
ThornJ, BrismanJ, TorenK. Adult-onset asthma is associated with self-reported mold or environmental tobacco smoke exposures in the home. Allergy, 56:287–292. 2001.
330.
TianoL, BelardinelliR, CarnevaliP, PrincipiF, SeddaiuG, LittarruGP. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: A double-blind, randomized controlled study. Eur Heart J, 28:2249–2255. 2007.
331.
TrautmannA, AkdisM, Schmid-GrendelmeierP, DischR, BrockerEB, BlaserK, AkdisCA. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol, 108:839–846. 2001.
332.
TrautmannA, Schmid-GrendelmeierP, KrugerK, CrameriR, AkdisM, AkkayaA, BrockerEB, BlaserK, AkdisCA. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol, 109:329–337. 2002.
333.
TredanielJ, BoffettaP, SaracciR, HirschA. Exposure to environmental tobacco smoke and adult non-neoplastic respiratory diseases. Eur Respir J, 7:173–185. 1994.
334.
UsatyukPV, VepaS, WatkinsT, HeD, ParinandiNL, NatarajanV. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal, 5:723–730. 2003.
335.
USEPA. Air Quality Criteria for Ozone and Related Photochemical Oxidants (Final)US Environmental Protection Agency: Washington, DCEPA/600/R–05/004aF-cF.2006.
336.
van AckerSA, KoymansLM, BastA. Molecular pharmacology of vitamin E: Structural aspects of antioxidant activity. Free Radic Biol Med, 15:311–328. 1993.
337.
VenarskeDL, BusseWW, GriffinMR, GebretsadikT, ShintaniAK, MintonPA, PeeblesRS, HamiltonR, WeisshaarE, VrtisR, HigginsSB, HartertTV. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis, 193:1536–1543. 2006.
338.
VrugtB, WilsonS, BronA, HolgateST, DjukanovicR, AalbersR. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J, 15:1014–1021. 2000.
339.
WangYZ, IngramJL, WaltersDM, RiceAB, SantosJH, Van HoutenB, BonnerJC. Vanadium-induced STAT-1 activation in lung myofibroblasts requires H2O2 and P38 MAP kinase. Free Radic Biol Med, 35:845–855. 2003.
340.
WardlawAJ. Eosinophils in the 1990s: New perspectives on their role in health and disease. Postgrad Med J, 70:536–552. 1994.
341.
WeissSJ, TestST, EckmannCM, RoosD, RegianiS. Brominating oxidants generated by human eosinophils. Science, 234:200–203. 1986.
342.
WinkDA, HanbauerI, LavalF, CookJA, KrishnaMC, MitchellJB. Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann NY Acad Sci, 738:265–278. 1994.
343.
WinkDA, NimsRW, DarbyshireJF, ChristodoulouD, HanbauerI, CoxGW, LavalF, LavalJ, CookJA, KrishnaMCet al.Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem Res Toxicol, 7:519–525. 1994.
344.
WispeJR, ClarkJC, BurhansMS, KroppKE, KorfhagenTR, WhitsettJA. Synthesis and processing of the precursor for human mangano-superoxide dismutase. Biochim Biophys Acta, 994:30–36. 1989.
345.
WongGH, GoeddelDV. Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science, 242:941–944. 1988.
346.
WoodLG, GargML, SimpsonJL, MoriTA, CroftKD, WarkPA, GibsonPG. Induced sputum 8-isoprostane concentrations in inflammatory airway diseases. Am J Respir Crit Care Med, 171:426–430. 2005.
XuW, ComhairSA, ZhengS, ChuSC, Marks-KonczalikJ, MossJ, HaqueSJ, ErzurumSC. STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation. Am J Physiol Lung Cell Mol Physiol, 285:L137–1–48. 2003.
349.
XuW, KanekoFT, ZhengS, ComhairSA, JanochaAJ, GoggansT, ThunnissenFB, FarverC, HazenSL, JenningsC, DweikRA, ArroligaAC, ErzurumSC. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J, 18:1746–1748. 2004.
350.
YamadaY, NakamuraH, AdachiT, SannoheS, OyamadaH, KayabaH, YodoiJ, ChiharaJ. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol Lett, 86:199–205. 2003.
351.
YamakuraF, TakaH, FujimuraT, MurayamaK. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem, 273:14085–14089. 1998.
352.
YehCT, ChingLC, YenGC. Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats. J Nutr Biochem, 20:163–171. 2009.
353.
YooJH, ErzurumSC, HayJG, LemarchandP, CrystalRG. Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress. J Clin Invest, 93:297–302. 1994.
354.
YoshimuraS, SuemizuH, TaniguchiY, ArimoriK, KawabeN, MoriuchiT. The human plasma glutathione peroxidase-encoding gene: organization, sequence and localization to chromosome 5q32. Gene, 145:293–297. 1994.
355.
ZhangH, JosephJ, FelixC, KalyanaramanB. Bicarbonate enhances the hydroxylation, nitration, and peroxidation reactions catalyzed by copper, zinc superoxide dismutase. Intermediacy of carbonate anion radical. J Biol Chem, 275:14038–14045. 2000.
356.
ZhangY, MarcillatO, GiuliviC, ErnsterL, DaviesKJ. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J Biol Chem, 265:16330–16336. 1990.
357.
ZhengL, NukunaB, BrennanML, SunM, GoormasticM, SettleM, SchmittD, FuX, ThomsonL, FoxPL, IschiropoulosH, SmithJD, KinterM, HazenSL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest, 114:529–541. 2004.
